Rationally Designed Ruthenium Complexes for Breast Cancer Therapy

Golara Golbaghi1, Annie Castonguay1

  • 1Organometallic Chemistry Laboratory for the Design of Catalysts and Therapeutics, INRS-Centre Armand-Frappier Santé Biotechnologie, Université du Québec, Laval, QC H7V 1B7, Canada.

Summary

Ruthenium complexes show promise for treating breast cancer, particularly hormone receptor-positive and triple-negative types. This review highlights rationally designed ruthenium compounds with bioactive ligands for enhanced anticancer drug development.